Browsing by Author "Cascante Serratosa, Marta"

Sort by: Order: Results:

  • Roca, Josep; Vargas, Claudia; Cano, Isaac; Selivanov, Vitaly; Barreiro Portela, Esther; Maier, Dieter; Falciani, Francesco; Wagner, Peter; Cascante Serratosa, Marta; García Aymerich, Judith; Kalko, Susana G.; Marin de Mas, Igor; Tegnér, Jesper; Escarrabill, Joan; Agustí García-Navarro, Àlvar; Gomez Cabrero, David; Synergy-COPD consortium (BioMed Central, 2014)
    Background and hypothesis: Heterogeneity in clinical manifestations and disease progression in Chronic Obstructive Pulmonary Disease (COPD) lead to consequences for patient health risk assessment, stratification and ...
  • Montcusí Ventura, Blanca; Madrid-Gambin, Francisco; Pozo Mendoza, Óscar J., 1975-; Marco, Santiago; Marin, Silvia; Mayol Girbau, Xavier; Pascual, Marta; Alonso, Sandra; Salvans Ruiz, Silvia; Jiménez Toscano, Marta; Cascante Serratosa, Marta; Pera Roman, Miguel (Wolters Kluwer (LWW), 2024)
    Background: Early detection of postoperative complications after colorectal cancer (CRC) surgery is associated with improved outcomes. The aim was to investigate early metabolomics signatures capable to detect patients at ...
  • Maier, Dieter; Kalus, Wenzel; Wolff, Martin; Kalko, Susana G.; Roca Torrent, Josep; Marin de Mas, Igor; Turan, Nil; Cascante Serratosa, Marta; Falciani, Francesco; Hernández, Miguel; Villà i Freixa, Jordi; Losko, Sascha (BioMed Central, 2011)
    Background: To enhance our understanding of complex biological systems like diseases we need to put all of the available data into context and use this to detect relations, pattern and rules which allow predictive hypotheses ...
  • Millares, Laura; Barreiro Portela, Esther; Cortes, Roldan; Martínez-Romero, Anabel; Balcells Nadal, Cristina; Cascante Serratosa, Marta; Enguita, Ana Belen; Álvarez, Carlos; Rami-Porta, Ramón; Sánchez de Cos, Julio; Seijo, Luis; Monsó Molas, Eduard; Grupo Colaborativo en Cáncer de Pulmón CIBERES-CIBERONC-SEPAR-Plataforma Biobanco Pulmonar (Elsevier, 2018)
    INTRODUCTION: Non-small cell lung cancer (NSCLC) patients diagnosed in early stage and surgically-treated have five-year mortality rate >20%. The identification of biomarkers able to predict progression and death may help ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking